TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
0.51
-0.05 (-9.57%)
At close: May 02, 2025, 3:59 PM
TransCode Therapeutics Revenue
TransCode Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, TransCode Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
7
Market Cap
11.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|